Page 19 - AIH-1-2

Artificial Intelligence in Health AI in the battle against COVID-19

53. Miner AS, Laranjo L, Kocaballi AB. Chatbots in the fight 65. Rohmetra H, Raghunath N, Narang P, Chamola V,
against the COVID-19 pandemic. NPJ Digit Med. 2020;3:65. Guizani M, Lakkaniga NR. AI-enabled remote monitoring
of vital signs for COVID-19: methods, prospects and
doi: 10.1038/s41746-020-0280-0
challenges. Computing. 2021;105:1-27.
54. Almalki M, Azeez F. Health chatbots for fighting COVID- doi: 10.1007/s00607-021-00937-7
19: A scoping review. Acta Inform Med. 2020;28:241.
66. Bokolo AJ. Application of telemedicine and eHealth
doi: 10.5455/aim.2020.28.241-247
technology for clinical services in response to COVID-19
55. Martin A, Nateqi J, Gruarin S, et al. An artificial pandemic. Health Technol (Berl). 2021;11:359-366.
intelligence-based first-line defence against COVID-19: doi: 10.1007/s12553-020-00516-4
Digitally screening citizens for risks via a chatbot. Sci
Rep. 2020;10:19012. 67. Webster P. Virtual health care in the era of COVID-19.
Lancet. 2020;395:1180-1181.
doi: 10.1038/s41598-020-75912-x
doi: 10.1016/S0140-6736(20)30818-7
56. Boucher EM, Harake NR, Ward HE, et al. Artificially
intelligent chatbots in digital mental health interventions: 68. Judson TJ, Odisho AY, Young JJ, et al. Implementation
A review. Expert Rev Med Devices. 2021;18:37-49. of a digital chatbot to screen health system employees
during the COVID-19 pandemic. J Am Med Inform Assoc.
doi: 10.1080/17434440.2021.2013200 2020;27:1450-1455.
57. Channa A, Popescu N, Skibinska J, Burget R. The rise doi: 10.1093/jamia/ocaa130
of wearable devices during the COVID-19 pandemic:
A systematic review. Sensors. 2021;21:5787. 69. Chadi MA, Mousannif H. A reinforcement learning based
decision support tool for epidemic control: Validation study
doi: 10.3390/s21175787 for COVID-19. Appl Artif Intell. 2022;36:2031821.
58. Mishra T, Wang M, Metwally AA, et al. Pre-symptomatic doi: 10.1080/08839514.2022.2031821
detection of COVID-19 from smartwatch data. Nat Biomed
Eng. 2020;4:1208-1220. 70. Guo X, Chen P, Liang S, et al. PaCAR: COVID-19 pandemic
control decision making via large-scale agent-based
doi: 10.1038/s41551-020-00640-6 modeling and deep reinforcement learning. Med Decis
59. Gandla K, Reddy KTK, Babu PV, Sagapola R, Sudhakar P. Making. 2022;42:1064-1077.
A review of artificial intelligence in treatment of COVID-19. doi: 10.1177/0272989X221107902
J Pharm Negat Results. 2022;13:254-264.
71. Ghahramani M, Pilla F. Leveraging artificial intelligence
60. Smith MD, Smith JC. Repurposing therapeutics for to analyze the COVID-19 distribution pattern based on
COVID-19: Supercomputer-Based Docking to the SARS- socioeconomic determinants. Sustain Cities Soc. 2021;69:102848.
CoV-2 Viral Spike Protein and Viral Spike Protein-Human
ACE2 Interface. ChemRxiv. 2020. doi: 10.1016/j.scs.2021.102848
doi: 10.26434/chemrxiv.11871402 72. Narayan K, Rathore H, Znidi F. Using epidemic modeling,
machine learning and control feedback strategy for policy
61. Zhou Y, Wang F, Tang J, Nussinov R, Cheng F. Artificial management of COVID-19. IEEE Access. 2022;10:98244-
intelligence in COVID-19 drug repurposing. Lancet Digit 98258.
Health. 2020;2:e667-e676.
doi: 10.1109/ACCESS.2022.3206790
doi: 10.1016/S2589-7500(20)30192-8
73. Wang H. The application of artificial intelligence in health
62. Senior AW, Evans R, Jumper J, et al. Improved protein care resource allocation before and during the COVID-19
structure prediction using potentials from deep learning. pandemic: Scoping Health Policy. JMIR AI. 2023;5:6.
Nature. 2020;577:706-710.
74. Yu L, Halalau A, Dalal B, et al. Machine learning methods
doi: 10.1038/s41586-019-1923-7 to predict mechanical ventilation and mortality in patients
63. Jang WD, Jeon S, Kim S, Lee SY. Drugs repurposed for with COVID-19. PLoS One. 2021;16:e0249285.
COVID-19 by virtual screening of 6,218 drugs and cell- doi: 10.1371/journal.pone.0249285
based assay. Proc Natl Acad Sci U S A. 2021;118:e2024302118.
75. Douville NJ, Douville CB, Mentz G, et al. Clinically
doi: 10.1073/pnas.2024302118 applicable approach for predicting mechanical ventilation
64. Kandeel M, Al-Nazawi M. Virtual screening and repurposing in patients with COVID-19. Br J Anaesth. 2021;126:578-589.
of FDA approved drugs against COVID-19 main protease. doi: 10.1016/j.bja.2020.11.034
Life Sci. 2020;251:117627.
76. Cinelli M, Quattrociocchi W, Galeazzi A, et al. The COVID-
doi: 10.1016/j.lfs.2020.117627 19 social media infodemic. Sci Rep. 2020;10:16598.

Volume 1 Issue 2 (2024) 13 doi: 10.36922/aih.2401